Correlation Between Design Therapeutics and ESSA Pharma

Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Design Therapeutics and ESSA Pharma, you can compare the effects of market volatilities on Design Therapeutics and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and ESSA Pharma.

Diversification Opportunities for Design Therapeutics and ESSA Pharma

0.03

Correlation Coefficient

Design Therapeutics  ESSA Pharma

Significant diversification

The 3 months correlation between Design and ESSA is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and ESSA Pharma go up and down completely randomly.

Pair Corralation between Design Therapeutics and ESSA Pharma

Given the investment horizon of 90 days Design Therapeutics is expected to under-perform the ESSA Pharma. In addition to that, Design Therapeutics is 2.86 times more volatile than ESSA Pharma. It trades about -0.05 of its total potential returns per unit of risk. ESSA Pharma is currently generating about -0.01 per unit of volatility. If you would invest  161.00  in ESSA Pharma on December 25, 2024 and sell it today you would lose (3.00) from holding ESSA Pharma or give up 1.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Design Therapeutics  vs.  ESSA Pharma

Design Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Design Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

ESSA Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, ESSA Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Design Therapeutics and ESSA Pharma

The main advantage of trading using opposite Design Therapeutics and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.

The idea behind Design Therapeutics and ESSA Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.